Table 1 Characteristics of study participants

From: Clinical utility of polygenic scores for cardiometabolic disease in Arabs

Characteristic

Case-control cohort (N = 5399)

Male sex, n (%)

3473 (64.3)

Age, mean (SD)

54.83 (14.82)

Coronary artery disease, n (%)

3491 (65.0)

Type 2 diabetes, n (%)

2979 (55.6)

Cardiomyopathy, n (%)

479 (9.3)

LDL cholesterola, mean (SD) [mg/dL]

135.82 (53.38)

HDL cholesterolb, mean (SD) [mg/dL]

45.20 (13.24)

Triglyceridesc, mean (SD) [mg/dL]

165.73 (111.87)

Systolic blood pressured, mean (SD) [mmHg]

146.61 (23.92)

Diastolic blood pressured, mean (SD) [mmHg]

83.06 (13.34)

Body mass index, mean (SD) [kg/m2]

29.31 (6.05)

Height, mean (SD) [m]

1.61 (0.09)

Current or former smoking, n (%)

2060 (38.3)

  1. The number of missing values varies across the characteristics.
  2. aLDL cholesterol levels were adjusted for statin, ezetimibe, and fibrate use.
  3. bHDL cholesterol levels were adjusted for fibrate use.
  4. cTriglycerides levels were adjusted for statin and fibrate use.
  5. dSystolic and diastolic blood pressures were adjusted for antihypertensive medication (ACE inhibitors, angiotensin receptor blocker, beta blockers, calcium channel blockers, diuretics, and nitrates) use.
Back to article page